RedHill Biopharma RDHL
NASDAQ RDHL
$0.50 +0.02 (+4.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

RedHill Biopharma (RDHL) Other Non Operating Income (2015)

Updated

RedHill Biopharma's Other Non Operating Income was $845,000 in the year ended Dec 31, 2017.

Analysis

RedHill Biopharma (RDHL) Other Non Operating Income (2015) Analysis & Trends

  • Per Business Quant data, Other Non Operating Income in earlier years was $100,000 in the year ended Dec 31, 2015 and -$100,000 in the year ended Dec 31, 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 RedHill Biopharma 7.38 Mn 7.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -906,000.00
Sep 30, 2015 1.02 Mn
API Access

RedHill Biopharma Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RDHL&period=max&api_key=YOUR_API_KEY